Management of nasal polyposis

B-ENT

Volumn 1, Issue SUPPL. 1, 2005, Pages 77-84

  Bachert, C ^a   Robillard, T ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b Clinique Ste Elisabeth ^*  (Belgium)

Author keywords

Guidelines; Management; Nasal polyposis

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; CORTICOSTEROID; DECONGESTIVE AGENT; GLUCOCORTICOID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MACROLIDE; METHYLPREDNISOLONE; MUCOLYTIC AGENT; PROTON PUMP INHIBITOR; STAPHYLOCOCCUS ENTEROTOXIN; STEROID;

ALLERGY; ASTHMA; CHRONIC SINUSITIS; CLINICAL TRIAL; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG HYPERSENSITIVITY; ENDOSCOPY; GASTROINTESTINAL SYMPTOM; HUMAN; INFLAMMATION; MEDICAL DECISION MAKING; NOSE POLYP; REVIEW; RHINOSINUSITIS; STAPHYLOCOCCUS AUREUS; TREATMENT FAILURE; URTICARIA; ALGORITHM;

ALGORITHMS; HUMANS; NASAL POLYPS;

EID: 33644877732     PISSN: 1781782X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Johansson L, Akerlund A, Holmberg K, Melen I, Bende M. Prevalence of nasal polyps in adults: the Skovde population-based study. Ann Otol Rhinol Laryngol. 2003;112:625-629.
2. Hedman J, Kaprio J, Poussa T, Nieminen MM. Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol 1999;28:717-722.
3. Larsen PL, Tos M. Origin of nasal polyps. Laryngoscope. 1991;101:305-312.
4. Larsen PL, Tos M. Site of origin of nasal polyps. Transcranially removed naso-ethmoidal blocks as a screening method for nasal polyps in autopsy material. Rhinology. 1995;33:185-188.
5. Larsen P, Tos M. Anatomic site of origin of nasal polyps: endoscopic nasal and paranasal sinus surgery as a screening method for nasal polyps in autopsy material. Am J Rhinol. 1996;10:211-216.
6. Drake-Lee A. Nasal polyps. In: Mygind N, Naclerio RM, Ed. Allergic and non-allergic rhinitis. Munksgaard, Copenhagen; 1993.
7. Larsen K, Tos M. The estimated incidence of symptomatic nasal polyps. Acta Otolaryngol. 2002;122:179-182.
8. Settipane GA, Chafee, FH. Nasal polyps in asthma and rhinitis. A review of 6,037 patients. J Allergy Clin Immunol. 1977;59:17-21.
9. Caplin I, Haynes JT, Spahn J. Are nasal polyps an allergic phenomenon? Ann Allergy. 1971;29:631-634.
10. Delaney JC. Aspirin idiosyncrasy in patients admitted for nasal polypectomy. Clin Otolaryngol Allied Sci. 1976;1:27-30.
11. Blumstein GI, Tuft LI. Allergy treatment in recurrent nasal polyposis: its importance and value. Am J Med Sci. 1957;234:269-280.
12. English G. Nasal polyposis. In: GM E, Ed. Otolaryngology. Harper and Row, Philadelphia; 1985:1-30.
13. Bachert C, Gevaert P, Holtappels G, Johansson SG, van Cauwenberge PI. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol. 2001;107:607-614.
14. Settipane G. Epidemiology of nasal polyps. In: Settipane G, Lund VJ, Bernstein JM, Tos M, Ed. Nasal polyps: epidemiology, pathogenesis and treatment. Oceanside Publications, Rhode Island; 1997:17-24.
15. Larsen K. The clinical relationship of nasal polyps to asthma. In: Settipane G, Lund VJ, Bernstein JM, Tos M, Ed. Nasal polyps: epidemiology, pathogenesis and treatment. Oceanside Publications, Rhode Island; 1997:97-104.
16. Larsen K. The clinical relationship of nasal polyps to asthma. Allergy Asthma Proc. 1996;17:243-249.
17. May A, Wagner D, Langenbeck U, Weber A. Family study of patients with aspirin intolerance and rhinosinusitis [in German]. HNO. 2000;48:650-654.
18. Bachert C, Van Cauwenberge PB. Inflammatory mechanisms in chronic sinusitis. Acta Otorhinolaryngol Belg. 1997;51:209-217.
19. Berger G, Kattan A, Bernheim J, Ophir DI. Polypoid mucosa with eosinophilia and glandular hyperplasia in chronic sinusitis: a histopathological and immunohistochemical study. Laryngoscope. 2002;112:738-745.
20. Rudack C, Stoll W, Bachert C. Cytokines in nasal polyposis, acute and chronic sinusitis. Am J Rhinol. 1998;12:383-388.
21. Hamilos DL, Leung DY, Wood R, et al. Eosinophil infiltration in nonallergic chronic hyperplastic sinusitis with nasal polyposis (CHS/NP) is associated with endothelial VCAM-1 upregulation and expression of TNF-alpha. Am J Respir Cell Mol Biol. 1996;15:443-450.
22. Hamilos DL, Leung DY, Wood R, et al. Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis. J Allergy Clin Immunol. 1995;96:537-544.
23. Bachert C, Wagenmann M, Hauser U, Rudack CI. IL-5 synthesis is upregulated in human nasal polyp tissue. J Allergy Clin Immunol. 1997;99:837-842.
24. Watelet JB, Bachert C, Claeys C, van Cauwenberge P. Matrix Metalloproteinases MMP-7, MMP-9 and their tissue inhibitor TIM-1: expression in chronic sinusitis versus nasal polyposis. Allergy. 2004;59:54-60.
25. Donovan R, Johansson SG, Bennich H, Soothill JF. Immunoglobulins in nasal polyp fluid. Int Arch Allergy Appl Immunol. 1970;37:154-166.
26. Bachert C, Gevaert P, Holtappels G, Cuvelier C, van Cauwenberge PI. Nasal polyposis: from cytokines to growth. Am J Rhinol. 2000;14:279-290.
27. Perez-Novo CA, Kowalski ML, Kuna P, et al. Aspirin sensitivity and IgE antibodies to Staphylococcus aureus enterotoxins in nasal polyposis: studies on the relationship. Int Arch Allergy Immunol. 2004;133:255-260.
28. Van Zele T, Gevaert P, Watelet JB, et al. Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis. J Allergy Clin Immunol. 2004;114:981-983.
29. Gevaert P, Holtappels G, Johansson SG, Cuvelier C, Cauwenberge P, Bachert C. Organisation of secondary lymphoid tissue and local IgE formation to Staphylococcus aureus enterotoxins in nasal polyps. Allergy. 2005;60:71-79.
30. Bachert C, Gevaert P, van Cauwenberge P. Staphylococcus aureus enterotoxins: a key in airway disease? Allergy. 2002;57:480-487.
31. Bachert C, Gevaert P, Howarth P, Holtappels G, van Cauwenberge P, Johansson SG. IgE to Staphylococcus aureus enterotoxins in serum is related to severity of asthma. J Allergy Clin Immunol. 2003;111:1131-1132.
32. Vento SI, Ertama LO, Hytonen ML, Wolff CH, Malmberg CH. Nasal poly posis: clinical course during 20 years. Ann Allergy Asthma Immunol. 2000;85:209-214.
33. Benninger MS, Senior BA. The development of the Rhinosinusitis Disability Index. Arch Otolaryngol Head Neck Surg. 1997;123:1175-1179.
34. Metson RB, Gliklich RE. Clinical outcomes in patients with chronic sinusitis. Laryngoscope. 2000;110:24-28.
35. Lund VJ, Mackay IS. Staging in rhinosinusitus. Rhinology. 1993;31:183-184.
36. Lildholdt T, Rundcrantz H, Lindqvist N. Efficacy of topical corticosteroid powder for nasal polyps: a double-blind, placebo-controlled study of budesonide. Clin Otolaryngol Allied. 1995;20:26-30.
37. Johansson L, Akerlund A, Holmberg K, Melen I, Stierna P, Bende M. Evaluation of methods for endoscopic staging of nasal polyposis. Acta Otolaryngol 2000;120:72-76.
38. Browne J, Hopkins J, Hopkins C, et al. The National Comparative Audit of Surgery for Nasal Polyposis and Chronic Rhinosinusitis. Royal College of Surgeons of England 2003 2003.
39. Lildholdt T, Rundcrantz H, Bende M, Larsen K. Glucocorticoid treatment for nasal polyps. The use of topical budesonide powder, intramuscular betamethasone, and surgical treatment. Arch Otolaryngol Head Neck Surg. 1997;123:595-600.
40. Lildholdt T, Fogstrup J, Gammelgaard N, Kortholm B, Ulsoe C. Surgical versus medical treatment of nasal polyps. Acta Otolaryngol. 1988;105:140-143.
41. Stevenson DD, Hankammer MA, Mathison DA, Christiansen SC, Simon RA. Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes. J Allergy Clin Immunol. 1996;98:751-758.
42. Stevenson DD. Aspirin desensitization in patients with AERD. Clin Rev Allergy Immunol. 2003;24:159-168.
43. Gosepath J, Schafer D, Mann WJ. Aspirin sensitivity: long term follow-up after up to 3 years of adaptive desensitization using a maintenance dose of 100 mg of aspirin a day [in German]. Laryngorhinootologie. 2002;81:732-738.
44. Lund VJ. Evidence-based surgery in chronic rhinosinusitis. Acta Otolaryngol. 2001;121:5-9.
45. McCulloch P, Taylor I, Sasako M, Lovett B, Griffin D. Randomised trials in surgery: problems and possible solutions. BMJ. 2002;324:1448-14451.
46. Ragab SM, Lund VJ, Scadding G. Evaluation of the medical and surgical treatment of chronic rhinosinusitis: a prospective, randomised, controlled trial. Laryngoscope. 2004;114:923-930.
47. Blomqvist EH, Lundblad L, Anggard A, Haraldsson PO, Stjarne P. A randomized controlled study evaluating medical treatment versus surgical treatment in addition to medical treatment of nasal polyposis. J Allergy Clin Immunol. 2001;107:224-228.